The catalyst changes the reactivity of the alkene and nitrogen-transfer reagent, or promotes coupling between an imine and a sulfur ylide. These activation pathways bring the reacting partners into a state that supports carbon-nitrogen bond formation. The specific catalyst and reaction design therefore influence which aziridine forms and whether stereochemical control can be achieved.
Stereoselectivity determines the three-dimensional arrangement of substituents in the newly formed aziridine. Organocatalytic systems can be designed to produce chiral aziridines, giving access to defined intermediates rather than mixtures of stereoisomers. This control matters because the resulting chiral building blocks can be carried into pharmaceutical and natural-product synthesis with their spatial information preserved.
Two principal partner combinations are highlighted: an alkene can react with a nitrogen-transfer reagent, or an imine can couple with a sulfur ylide. Although these routes use different starting partners, both enable formation of carbon-nitrogen bonds within the strained three-membered ring. This pathway flexibility helps chemists adapt the method to different synthetic targets.
A typical workflow selects the desired alkene and nitrogen-transfer reagent, or an imine and sulfur ylide, then introduces a suitable small-molecule organic catalyst to promote their coupling. The reaction design is adjusted for the required reactivity and stereochemical outcome. Product analysis then focuses on whether the intended aziridine and, when relevant, its chiral form were obtained.
Chemists may choose organocatalytic aziridination when a metal-free strategy is desirable or when catalyst tunability and asymmetric synthesis are important. Avoiding reliance on metal catalysts can support a different overall reaction design, while small organic catalysts offer opportunities to adjust reactivity and stereochemical selectivity. These features make the approach relevant to complex molecule construction.
Aziridines are valuable strained nitrogen heterocycles and versatile building blocks for organic synthesis. Their preparation can provide chiral intermediates that support the construction of pharmaceutical compounds and natural products. In this context, organocatalytic aziridination connects carbon-nitrogen bond formation with downstream molecular design, especially when the synthesis requires metal-free conditions or stereochemically defined intermediates.